Kirk William Hering

Title: Kirk William Hering: Innovator in Cannabinoid Conjugate Molecules

Introduction

Kirk William Hering is a notable inventor based in Salem, OR (US). He has made significant contributions to the field of cannabinoid research, holding a total of 3 patents. His work focuses on the development of innovative conjugate molecules that have potential therapeutic applications.

Latest Patents

Hering's latest patents include groundbreaking work on cannabinoid conjugate molecules. These patents disclose conjugate molecules formed from an active agent linked to a cannabinoid moiety through a specified linker with ester and amide end groups. The active agent can be a COX-2 inhibitor moiety, while the cannabinoid moiety can be a cannabidiol moiety. These conjugate molecules are contemplated to potentially be effective in the treatment of various medical conditions.

Career Highlights

Kirk William Hering is currently associated with Akos Biosciences, Inc., where he continues to advance his research in cannabinoid conjugate molecules. His innovative approach and dedication to the field have positioned him as a key figure in cannabinoid research.

Collaborations

Hering collaborates with talented individuals such as Paul M Hershberger and Yinghui Liu, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Kirk William Hering's work in cannabinoid conjugate molecules exemplifies the potential of innovative research in addressing medical challenges. His contributions to the field are paving the way for future advancements in cannabinoid therapies.